Myeloproliferative Disorders: Usefulness of X-linked Probes in Diagnosis
Overview
Affiliations
Myeloproliferative disorders are neoplasms of the pluripotent hematopoietic stem cell. Accurate diagnosis and distinction from reactive processes can be difficult therein with cytogenetic analysis only being useful in a minority of patients. Use of X-linked restriction fragment length polymorphism and methylation analysis has enabled clonal analysis to be performed in up to 50% of females, significantly increasing the proportion of analyzable patients over methods dependent on glucose-6-phosphate dehydrogenase heterozygosity. Using hypoxanthine phosphoribosyl transferase and phosphoglycerate kinase probes, we have demonstrated monoclonality of peripheral blood leukocytes in three females with myeloproliferative disorders who had uninformative chromosomal analysis. This technique greatly enhances the diagnosis of early myeloproliferative disorder.
Myeloproliferative Neoplasms: Challenging Dogma.
Spivak J J Clin Med. 2024; 13(22).
PMID: 39598101 PMC: 11595126. DOI: 10.3390/jcm13226957.
Spivak J Curr Treat Options Oncol. 2018; 19(2):12.
PMID: 29516275 DOI: 10.1007/s11864-018-0529-x.
Sacchi S, Leoni P, Liberati M, Riccardi A, Tabilio A, Tartoni P Ann Hematol. 1994; 68(5):247-50.
PMID: 8018766 DOI: 10.1007/BF01737425.
Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.
Gilliland D, Blanchard K, Levy J, Perrin S, BUNN H Proc Natl Acad Sci U S A. 1991; 88(15):6848-52.
PMID: 1862109 PMC: 52186. DOI: 10.1073/pnas.88.15.6848.